In glioma, tumor-associated microglia are converted to a phenotype with pro-tumorigenic features by the tumor microenvironment through chemokines such as CXCL1, and targeting these microglia can reduce tumor growth (10, 14). Here, CXCL1 is linked to neoplasm.